NO970903L - Fusjonerte indol- og kinoksalderivater, deres fremstilling og anvendelse - Google Patents

Fusjonerte indol- og kinoksalderivater, deres fremstilling og anvendelse

Info

Publication number: NO970903L
Authority: NO; Norway
Prior art keywords: alkyl; hydrogen; amino; alkoxy; phenyl
Prior art date: 1994-09-14

Application number

NO970903A

Other languages

English (en)

Other versions

NO970903D0 (no

NO308851B1 (no

Inventor

Peter Moldt

Frank Waetjen

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-14

Filing date

1997-02-27

Publication date

1997-05-07

1997-02-27 Application filed by Neurosearch As filed Critical Neurosearch As

1997-02-27 Publication of NO970903D0 publication Critical patent/NO970903D0/no

1997-05-07 Publication of NO970903L publication Critical patent/NO970903L/no

2000-11-06 Publication of NO308851B1 publication Critical patent/NO308851B1/no

Links

SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 2
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 9
229910052739 hydrogen Inorganic materials 0.000 abstract 6
239000001257 hydrogen Substances 0.000 abstract 6
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
-1 hydroxy, amino Chemical group 0.000 abstract 5
125000003545 alkoxy group Chemical group 0.000 abstract 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000001424 substituent group Chemical group 0.000 abstract 4
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 3
125000005843 halogen group Chemical group 0.000 abstract 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000004429 atom Chemical group 0.000 abstract 1
125000005605 benzo group Chemical group 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO970903A 1994-09-14 1997-02-27 Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen NO308851B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK105494		1994-09-14
PCT/EP1995/003594 WO1996008495A1 (en)	1994-09-14	1995-09-12	Fused indole and quinoxaline derivatives, their preparation and use

Publications (3)

Publication Number	Publication Date
NO970903D0 NO970903D0 (no)	1997-02-27
NO970903L true NO970903L (no)	1997-05-07
NO308851B1 NO308851B1 (no)	2000-11-06

Family

ID=8100467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970903A NO308851B1 (no)	1994-09-14	1997-02-27	Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen

Country Status (12)

Country	Link
US (1)	US5801174A (no)
EP (1)	EP0781285B1 (no)
JP (1)	JP3164372B2 (no)
AT (1)	ATE188701T1 (no)
AU (1)	AU686888B2 (no)
CA (1)	CA2199614C (no)
DE (1)	DE69514533T2 (no)
EE (1)	EE03772B1 (no)
FI (1)	FI112486B (no)
NO (1)	NO308851B1 (no)
NZ (1)	NZ293266A (no)
WO (1)	WO1996008495A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA54403C2 (uk)	1996-10-01	2003-03-17	Н'Юросерч А/С	Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
FR2781482B1 (fr) *	1998-07-27	2001-08-31	Adir	Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK1183025T3 (da)	1999-05-19	2009-05-04	Painceptor Pharma Corp	Hæmmere af proton-styrede kationskanaler og deres anvendelse til behandling af iskæmiske lidelser
EP1255734B1 (en) *	2000-01-24	2006-06-21	NeuroSearch A/S	Isatine derivatives with neurotrophic activity
WO2007059608A1 (en)	2005-11-23	2007-05-31	Painceptor Pharma Corporation	Compositions and methods for modulating gated ion channels
US7825122B2 (en)	2005-12-14	2010-11-02	Amgen Inc.	Diaza heterocyclic sulfonamide derivatives and their uses
CA2652307A1 (en) *	2006-04-10	2007-10-18	Painceptor Pharma Corporation	Compositions and methods for modulating gated ion channels
US20090246134A1 (en) *	2007-05-30	2009-10-01	Painceptor Pharma Corporation	Compositions and methods for modulating gated ion channels
CA2868238A1 (en)	2012-04-18	2013-10-24	Ramot At Tel Aviv University Ltd.	Lipidated glycosaminoglycan particles for the delivery of nucleic acids
WO2016114655A1 (en) *	2015-01-12	2016-07-21	Ry Pharma B.V.	Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation
WO2017065602A1 (en) *	2015-10-13	2017-04-20	Ry Pharma B.V.	Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9204914A (es) *	1991-08-28	1993-07-01	Frank Watjen	Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
ATE157977T1 (de) *	1992-10-13	1997-09-15	Warner Lambert Co	Chinoxalinderivate als eaa antagonisten

1995
- 1995-09-12 EE EE9700051A patent/EE03772B1/xx not_active IP Right Cessation
- 1995-09-12 AT AT95932730T patent/ATE188701T1/de not_active IP Right Cessation
- 1995-09-12 AU AU35665/95A patent/AU686888B2/en not_active Ceased
- 1995-09-12 JP JP50990896A patent/JP3164372B2/ja not_active Expired - Fee Related
- 1995-09-12 DE DE69514533T patent/DE69514533T2/de not_active Expired - Lifetime
- 1995-09-12 NZ NZ293266A patent/NZ293266A/en unknown
- 1995-09-12 US US08/809,086 patent/US5801174A/en not_active Expired - Lifetime
- 1995-09-12 CA CA002199614A patent/CA2199614C/en not_active Expired - Fee Related
- 1995-09-12 WO PCT/EP1995/003594 patent/WO1996008495A1/en not_active Ceased
- 1995-09-12 EP EP95932730A patent/EP0781285B1/en not_active Expired - Lifetime
1997
- 1997-02-25 FI FI970785A patent/FI112486B/fi active
- 1997-02-27 NO NO970903A patent/NO308851B1/no unknown

Also Published As

Publication number	Publication date
FI112486B (fi)	2003-12-15
NZ293266A (en)	1998-01-26
EE03772B1 (et)	2002-06-17
ATE188701T1 (de)	2000-01-15
EP0781285A1 (en)	1997-07-02
NO970903D0 (no)	1997-02-27
US5801174A (en)	1998-09-01
EE9700051A (et)	1997-08-15
DE69514533T2 (de)	2000-07-06
CA2199614A1 (en)	1996-03-21
JPH09511525A (ja)	1997-11-18
AU3566595A (en)	1996-03-29
FI970785A7 (fi)	1997-03-13
DE69514533D1 (de)	2000-02-17
JP3164372B2 (ja)	2001-05-08
FI970785A0 (fi)	1997-02-25
EP0781285B1 (en)	2000-01-12
CA2199614C (en)	2000-02-22
AU686888B2 (en)	1998-02-12
NO308851B1 (no)	2000-11-06
WO1996008495A1 (en)	1996-03-21

Publication	Publication Date	Title
SG128491A1 (en)	2007-01-30	Heterocyclic sulfonamide inhibitors of beta amyloid production
NO981609D0 (no)	1998-04-07	Fusjonerte tropanderivater som inhiberer for neurotransmitteropptak
NO970903L (no)	1997-05-07	Fusjonerte indol- og kinoksalderivater, deres fremstilling og anvendelse
NZ528997A (en)	2004-12-24	Sulfonamides
NO20050666L (no)	2005-03-11	2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO305287B1 (no)	1999-05-03	AMPA antagonister
HUP9700595A1 (hu)	2000-08-28	Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
DK0902684T3 (da)	2004-03-29	Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler
NO992676L (no)	1999-07-29	1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO970904L (no)	1997-04-24	Indol-2,3-dion-3-oksim-derivater, deres fremstilling og anvendelse
MXPA04005077A (es)	2004-08-19	Derivados de benzotiazol.
DE69510510D1 (de)	1999-08-05	N-benzoylmethylsubstituierte paroxetinderivate
DK0699197T3 (da)	2000-08-07	4-p-flourbenzoyl-1-piperidinyl-propoxy-chromen-4-on-derivater, deres fremstilling og deres anvendelse i behandlingen af psy
DK0783504T3 (da)	2000-08-14	(1,2,4)triazolo (4,3-a)guinoxalinon-derivater, deres fremstilling og anvendelse som antagonister af ampa-receptorer
ES2161892T3 (es)	2001-12-16	Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1.